Bacillus cereus infections in Traumatology-Orthopaedics Department: Retrospective investigation and improvement of healthcare practices

Journal of Infection

Volumn 50, Issue 1, 2005, Pages 22-30

  Dubouix, A ^a   Bonnet, E ^b   Alvarez, M ^b   Bensafi, H ^a   Archambaud, M ^a   Chaminade, B ^a   Chabanon, G ^a   Marty, N ^a  

^a CHU RANGUEIL   (France)

^b CHU PURPAN   (France)

Author keywords

Bacillus cereus; Ciprofloxacin; Ground contamination; PFGE; RAPD; Wound infections

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; AMUKINE; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; BETA LACTAM ANTIBIOTIC; BETAMETHASONE VALERATE; BETASCRUB; CEFALOTIN; CEFOTAXIME; CHLORHEXIDINE; CHLORHEXIDINE GLUCONATE; CIPROFLOXACIN; ERYTHROMYCIN; GENTAMICIN; IMIPENEM; METRONIDAZOLE; MINOCYCLINE; NETILMICIN; PENICILLIN G; POVIDONE IODINE; PRISTINAMYCIN; RIFAMPICIN; SODIUM HYPOCHLORIDE; TOBRAMYCIN; UNCLASSIFIED DRUG; VANCOMYCIN;

ADOLESCENT; ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; BACILLUS CEREUS; BACTERIAL INFECTION; BACTERIUM ISOLATION; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; DRUG EFFICACY; EPIDEMIC; HOSPITAL ADMISSION; HUMAN; MALE; MOLECULAR CLONING; NONHUMAN; OPEN FRACTURE; ORTHOPEDICS; PULSED FIELD GEL ELECTROPHORESIS; RANDOM AMPLIFIED POLYMORPHIC DNA; RETROSPECTIVE STUDY; SCREENING TEST; TRAUMATOLOGY; WOUND INFECTION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS, LOCAL; BACILLACEAE INFECTIONS; BACILLUS CEREUS; CIPROFLOXACIN; DELIVERY OF HEALTH CARE; ELECTROPHORESIS, GEL, PULSED-FIELD; FEMALE; HOSPITALIZATION; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; ORTHOPEDICS; RANDOM AMPLIFIED POLYMORPHIC DNA TECHNIQUE; RETROSPECTIVE STUDIES; SOIL POLLUTANTS; TRAUMATOLOGY; WOUND INFECTION;

EID: 11144290249     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jinf.2004.05.012     Document Type: Article

References (22)

1. Drobniewski F.A. Bacillus cereus and related species Clin Microbiol Rev 6 1993 324-338
2. Richard V. van der Auwera P. Snoeck R. Daneau D. Meunier F. Nosocomial bactaeremia caused by Bacillus species Eur J Clin Microbiol Infect Dis 7 1988 783-785
3. Turnbull P.C.B. Kramer J.M. Murray P.R. Baron E.J. Pfaller M.A. Tenover F.C. Yoken R.H. Manual of clinical microbiology 6th ed. 1995 ASM Press Washington DC
4. Akesson A. Hedstrom S.A. Ripa T. Bacillus cereus: A significant pathogen in postoperative and post-traumatic wounds on Orthopaedic wards Scand J Infect Dis 23 1991 71-77
5. Hsueh P.R. Teng L.J. Ho S.W. Hsieh W.C. Luh K.T. Clinical, microbiological characteristics of Flavobacterium indologenes infections associated with indwelling devices J Clin Microbiol 34 1996 1908-1913
6. Hsueh P.R. Teng L.J. Yang P.C. Chen Y.C. Ho S.W. Luh K.T. Persistence of a multi-drug resistant Pseudomonas aeruginosa clone in an intensive care unit J Clin Microbiol 36 1998 1347-1351
7. Harrell L.J. Andersen G.L. Wilson K.H. Genetic variability of Bacillus anthracis and related species J Clin Microbiol 26 1995 1571-1574
8. Tenover F.C. Arbeit R.D. Goering R.V. Mickelsen P.A. Murray B. Persing D.H. Swaminathan B. Interpreting chromosomal DNA restriction patterns produced by Pulse-Field Gel Electrophoresis: Criteria for bacterial strain typing J Clin Microbiol 33 1995 2233-2239
9. Turnbull P.C.B. Korgensen K. Kramer J.M. et al. Severe clinical conditions associated with Bacillus cereus and the apparent involvement of exotoxins J Clin Pathol 32 1979 289-293
10. Turnbull P.C.B. Kramer J.M. Non-gastrointestinal Bacillus cereus infections: An analysis of exotoxin production by strains isolated over a two-year period J Clin Pathol 36 1983 1091-1096
11. Alouf J.E. Geoffroy C. The family of antigenically-related, cholesterol-binding ('sulphydryl-activated') cytolytic toxins Alouf J.E. Freer J.H. et al. Sourcebook of bacterial protein toxins 1991 147-186 Academic Press London
12. Liu P.Y. Ke S.C. Chen S.L. Use of Pulse-Fiel Gel Electrophoresis to investigate a pseudo-outbreak of Bacillus cereus in a Pediatric unit J Clin Microbiol 35 1997 1533-1535
13. Bryce E.A. Smith J.A. Tweeddale M. Andruschak B.J. Maxwell M.R. Dissemination of Bacillus cereus in an intensive care unit Infect Control Hosp Epidemiol 14 1993 459-462
14. Hsueh P.R. Teng L.J. Yang P.C. Pan H.L. Ho S.W. Luh K.T. Nosocomial pseudoepidemic caused by Bacillus cereus traced to contaminated ethyl alcohol from a liquor factory J Clin Microbiol 37 1998 2280-2284
15. Dryden M.S. Kramer J.M. Toxigenic Bacillus cereus as a cause of wound infections in the tropics J Infect 15 1987 207-212
16. Hernandez E, Dubrous P, Deloynes B, Cavallo JD. Infections and superinfections due to Bacillus cereus following severe war injuries of French soldiers in former Yugoslavia and the Gulf war. K110. 1996; 36th ICAAC, New Orleans.
17. Barrie D. Hoffman P.N. Wilson J.A. Kramer J.M. Contamination of hospital linen by Bacillus cereus Epidemiol Infect 113 1994 297-306
18. National Committee for Clinical Laboratory Standards 1998. Performance standard for antimicrobial susceptibility testing. Eight informational supplements. M100-S8. National Committee for Clinical Laboratory Standards. Wayne, PA.
19. Morrell R.M. Wasilauskas B.L. Tracking laboratory contamination by using a Bacillus cereus pseudoepidemic as an example J Clin Microbiol 30 1992 1469-1473
20. Sabath L.D. Abraham E.P. Cephalosporinase and penicillinase activity of Bacillus cereus Antimicrob Agents Chemother 5 1965 392-397
21. Weber D.J. Saviteer S.M. Rutala W.A. Thomann C.A. In vitro susceptibility of Bacillus spp. to selected antimicrobial agents Antimicrob Agents Chemother 32 1988 642-645
22. Conrood J.D. Leadley P.J. Eickhoff T.C. Antibiotic susceptibility of Bacillus species J Infect Dis 123 1971 102-105